Bad Blood: Secrets and Lies in a Silicon Valley Startup image

October 2, 2018 5:00 PM
Lectures and Panels
2018-2019
2011-2012
Wasserstein Hall, Milstein East BC (2036)
Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA

Please join us for a conversation with John Carreyrou, Investigative reporter for the Wall Street Journal and author of the New York Times bestseller Bad Blood: Secrets and Lies in a Silicon Valley Startup

Complimentary copies of Bad Blood will be available for audience members.

Please help us plan - RSVP here!

This event is hosted by Cambridge ScienceHarvard College Cabot House, and the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School.​

Panelists

  • I. Glenn Cohen, James A. Attwood and Leslie Williams Professor of Law, Harvard Law School and Faculty Director, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School

  • Rakesh Khurana, Danoff Dean of Harvard College; Marvin Bower Professor of Leadership Development, Harvard Business School; Professor of Sociology, Harvard University; and Faculty Dean of Cabot House

  • Akiko Mikumo - Fellow Harvard Advanced Leadership Initiative, Retired M & A Partner Weil, Gotshal & Manges

  • Moderator: Douglas Eby, Senior Fellow, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard Law School and CEO, Cambridge Science

John Carreyrou is a member of The Wall Street Journal’s investigative reporting team. He joined the Journal in 1999 and has been based in Brussels, Paris, and New York for the paper. Mr. Carreyrou has covered a number of topics at the Journal, ranging from Islamist terrorism when he was on assignment in Europe, to the pharmaceutical industry. In 2015, he won a Pulitzer Prize for Investigative Reporting with several colleagues for a series of articles exposing fraud and abuse in Medicare, the federal health program for the elderly and disabled. Earlier in his career, he was also part of a Journal team that won a Pulitzer Prize for Explanatory Reporting for its coverage of corporate scandals. His coverage of the Silicon Valley blood-testing company Theranos has won George Polk, Gerald Loeb, and Barlett & Steele awards. Born in New York and raised in Paris, Mr. Carreyrou received a bachelor’s degree from Duke University. He currently resides in Brooklyn with his wife and three children.

Praise for Bad Blood

"You will not want to put this riveting, masterfully reported book down. No matter how bad you think the Theranos story was, you'll learn that the reality was actually far worse." —Bethany McLean, bestselling coauthor of The Smartest Guys in the Room and All the Devils Are Here

"[A] chilling, third-person narrative of how Holmes came up with a fantastic idea that made her, for a while, the most successful woman entrepreneur in Silicon Valley… Prizewinning Wall Street Journal reporter John Carreyrou tells [this story] virtually to perfection… [His] description of Holmes as a manic leader who turned coolly hostile when challenged is ripe material for a psychologist… His recounting of his efforts to track down sources—many of whom were being intimidated by Theranos’s bullying lawyer, David Boies—reads like a West Coast version of 'All the President's Men.'" —Roger Lowenstein, New York Times Book Review

"In Bad Blood, acclaimed investigative journalist John Carreyrou, who broke the story in 2015, presents comprehensive evidence of the fraud perpetrated by Theranos chief executive Elizabeth Holmes... He unveils many dark secrets of Theranos that have not previously been laid bare…  The combination of these brave whistle-blowers, and a tenacious journalist who interviewed 150 people (including 60 former employees) makes for a veritable page-turner." —Eric Topol, Nature

"Engrossing… Bad Blood boasts movie-scene detail… Theranos, Carreyrou writes, was a revolving door, as Holmes and Balwani fired anyone who voiced even tentative doubts… What’s frightening is how easy it is to imagine a different outcome, one in which the company’s blood-testing devices continued to proliferate. That the story played out as it did is a testament to the many individuals who spoke up, at great personal risk." —Jennifer Couzin-Frankel, Science

This event is hosted by Cambridge ScienceHarvard College Cabot House, and the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School.

Tags

bioethics   biotechnology   fda   health law policy   medical safety   public health   regulation